Skip to main content

Advertisement

Table 1 Characteristics of survey respondents by study arm

From: The acceptability and cost of a home-based chlamydia retesting strategy: findings from the REACT randomised controlled trial

Baseline characteristics Overall Clinic arm Home arm p-valuea
n (%) n (%) n (%)
All 445 (100) 209 (47.0) 236 (53.0)  
Age group     0.480
  < 30 294 (66.1) 137 (65.6) 157 (66.5)
 30–39 111 (24.9) 54 (25.8) 57 (24.2)
 40–49 23 (5.2) 8 (3.8) 15 (6.4)
 50+ 17 (3.8) 10 (4.8) 7 (3.0)
Risk group     0.491
 Women 150 (33.7) 71 (34.0) 79 (33.5)
 Heterosexual men 130 (29.2) 56 (26.8) 74 (31.4)
 MSM 165 (37.1) 82 (39.2) 83 (35.2)
Who they live with?     0.233
 Partner 65 (14.6) 31 (14.8) 34 (14.4)
 Friends / flatmates 237 (53.3) 109 (52.2) 128 (54.2)
 Parents 49 (11.0) 26 (12.4) 23 (9.7)
 Alone 82 (18.4) 41 (19.6) 41 (17.4)
 Other 12 (3.0) 2 (1.0) 10 (4.2)
Country of birth     0.870
 Australia 215 (54.8) 103 (55.4) 112 (54.4)
 Asia 48 (12.2) 22 (11.8) 26 (12.6)
 Europe 118 (30.1) 55 (29.6) 63 (30.6)
 Other 11 (2.9) 6 (3.2) 5 (2.4)
Previous CT diagnosis     0.841
 Yes 56 (12.6) 27 (12.9) 29 (12.3)
 No 389 (87.4) 182 (87.1) 207 (87.7)
Condom use in last 3 months (pre-diagnosis)     0.432
 Inconsistent (never/ sometimes) 333 (81.8) 162 (84.4) 171 (79.5)
 Consistent (always) 74 (18.2) 30 (15.6) 44 (20.5)
Number of sexual partners last 3 months     0.397
 0 26 (5.9) 10 (4.8) 16 (6.8)
 1 117 (26.3) 62 (29.8) 55 (23.3)
 2–5 221 (49.8) 101 (48.6) 120 (50.8)
  > 5 80 (18.0) 35 (16.8) 45 (19.1)
STI symptomsb at baseline     0.503
 Yes 196 (44.0) 96 (45.9) 100 (42.4)
 No 249 (56.0) 113 (54.1) 136 (57.6)
  1. Note: Data for some variables were not available for all participants
  2. MSM men who have sex with men, CT Chlamydia trachomatis
  3. aChi2 or Fisher’s exact test was used when appropriate
  4. bAnal and/or urogenital symptoms